Influence of Pelvic Intensity-Modulated Radiation Therapy With Concurrent Cisplatin-Based Chemotherapy of Cervical Cancer on the Vaginal Microbiome

被引:8
|
作者
Jiang, Li [1 ]
Li, Bo [1 ]
Zhang, Yong [1 ]
Ma, Shanshan [1 ]
Liu, Chang [1 ]
Liang, Feifei [1 ]
Wei, Zhuxin [1 ]
Huang, Tingting [1 ]
Wang, Rensheng [1 ]
机构
[1] Guangxi Med Univ, Dept Radiat Oncol, Affiliated Hosp 1, Nanning, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
vaginal microbiome; cervical cancer; intensity-modulated radiation therapy; radiochemotherapy; 16S rRNA sequencing; INTRAEPITHELIAL NEOPLASIA; RADIOTHERAPY; SENSITIVITY;
D O I
10.3389/fonc.2021.615439
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pelvic intensity-modulated radiation therapy (IMRT) combined with concurrent chemotherapy is an effective treatment for cervical cancer; however, radiation resistance impairs its clinical benefit. The vaginal microbiome plays an important but poorly understood role in cancer radiochemotherapy. In this study, we investigated the effects of treatment on the overall composition and alteration of the vaginal microbiome in patients receiving pelvic IMRT with concurrent cisplatin-based chemotherapy. We collected samples from twenty patients with cervical cancer and six healthy controls and performed 16S rRNA sequencing. Vaginal microbial composition analysis revealed significant differences between the two groups, but no significant differences between radiation treatment time points. However, the relative abundances of Gammaproteobacteria, Gemmatimonadetes, Gemmatimonadales, Pseudomonadales, Gemmatimonadaceae, Rikenellaceae, Acinetobacter, Desulfovibrio, Prevotella 9, Rikenellaceae RC9 gut group, Turicibacter, and the metagenome increased with time. The results encourage further study into the effects of the vaginal microbiome on cervical cancer treatment strategies, especially radiochemotherapy. Better understanding of these effects could inform new therapeutic approaches to enhance the efficacy of radiochemotherapy.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] OTOTOXICITY AFTER INTENSITY-MODULATED RADIATION THERAPY AND CISPLATIN-BASED CHEMOTHERAPY IN CHILDREN WITH MEDULLOBLASTOMA
    Paulino, Arnold C.
    Lobo, Mark
    Teh, Bin S.
    Okcu, M. Fatih
    South, Michael
    Butler, E. Brian
    Su, Jack
    Chintagumpala, Murali
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (05): : 1445 - 1450
  • [2] Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer
    Chen, Chien-Chih
    Lin, Jin-Ching
    Jan, Jian-Sheng
    Ho, Shih-Chu
    Wang, Lily
    [J]. GYNECOLOGIC ONCOLOGY, 2011, 122 (01) : 9 - 13
  • [3] Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer
    Wang, Shu-Lian
    Liao, Zhongxing
    Liu, Helen
    Ajani, Jaffer
    Swisher, Stephen
    Cox, James D.
    Komaki, Ritsuko
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (34) : 5501 - 5508
  • [4] Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer
    Helen Liu
    Jaffer Ajani
    Stephen Swisher
    James D Cox
    Ritsuko Komaki
    [J]. World Journal of Gastroenterology, 2006, (34) : 5501 - 5508
  • [5] Outcomes for Patients With Cervical Cancer Treated With Extended-Field Intensity-Modulated Radiation Therapy and Concurrent Cisplatin
    Jensen, Lindsay G.
    Hasselle, Michael D.
    Rose, Brent S.
    Nath, Sameer K.
    Hasan, Yasmin
    Scanderbeg, Dan J.
    Yashar, Catheryn M.
    Mundt, Arno J.
    Mell, Loren K.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (01) : 119 - 125
  • [6] Intensity-modulated Radiation Therapy With Concurrent Chemotherapy for Anal Cancer Outcomes and Toxicity
    Mitchell, Melissa P.
    Abboud, Mirna
    Eng, Cathy
    Beddar, A. Sam
    Krishnan, Sunil
    Delclos, Marc E.
    Crane, Christopher H.
    Das, Prajnan
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (05): : 461 - 466
  • [7] The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy
    Chen, Chien-Chih
    Wang, Lily
    Lin, Jin-Ching
    Jan, Jian-Sheng
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2015, 114 (03) : 231 - 237
  • [8] Dosimetric Predictors of Acute Hematologic Toxicity Due to Intensity-Modulated Pelvic Radiation Therapy with Concurrent Chemotherapy for Chinese Rectal and Cervical Cancer Patients
    Yang, Y.
    Li, W.
    Qian, J.
    Zhang, J.
    Shen, Y.
    Tian, Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E24 - E24
  • [9] Intensity-Modulated Radiation Therapy Without Concurrent Chemotherapy for Stage IIB Nasopharyngeal Cancer
    Tham, Ivan Weng Keong
    Lin, Shaojun
    Pan, Jianji
    Han, Lu
    Lu, Jiade J.
    Wee, Joseph
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (03): : 294 - 299
  • [10] Re-irradiation with intensity-modulated radiation therapy for pelvic recurrent cervical cancer
    Kang, H. J.
    Kimm, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1157 - S1157